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RNAIII is the key effector of the accessory gene regulator (agr) system. It is a regulatory RNA
(514 nucleotides long) that acts at both transcription and translation level to regulate the produc-
tion of numerous toxins, enzymes and cell surface proteins. Here, we reveal that map (major
histocompatibility complex class II analogous protein) is positively regulated by RNAIII. Our fur-
ther study indicates that the 108–135 nt fragment of RNAIII acts as an antisense RNA and anneals
to map mRNA, forming RNA duplexes. The interaction between RNAIII and map mRNA may acti-
vate translation initiation. This may be helpful for understanding the regulation of virulence in
S. aureus.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Staphylococcus aureus is a major community- and hospital-
acquired pathogen that can commonly cause both local and
systemic infections in humans [1]. The capacity of S. aureus to cause
disease depends on the adaptation to the host and the secretion of
the virulence factors. The adhered and secreted factors in S. aureus
are coordinately controlled by a complex network which is inﬂu-
enced by extracellular and intracellular signals [2]. The network
includes several two-component regulatory systems such as agr,
sae, arl, srrAB [3–7]. The agr system is known to be the important
global regulator of staphylococcal virulence because that agr
mutant is attenuated for virulence in several animal models [8].
RNAIII, a 514-nt RNA, is known as the key effecter of the agr system
[9], which is recognized as a star regulator that up-regulates pro-
duction of extracellular virulence factors such as hla [10], and
down-regulates production of surface virulence factors such as
spa at the translational level [11]. In addition, some regulatory pro-
teins are the targets of RNAIII, so it is considered that RNAIII may
indirectly control the downstream genes expression through regu-
lating the level of transcriptional regulators [8,12–15]. The second-
ary structure of RNAIII is conserved among several staphylococcalchemical Societies. Published by E
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8163140 (O).species and characterized by 14 stem-loop motifs [9]. The previous
studies show that RNAIII regulates the expression of target genes
through respectively different loops by an antisense mechanism
[11,15].
Map, also designated as Eap (extracellular adherence protein),
is one of S. aureus surface adhesions and an important mediator
in the immune response to staphylococcal infection [16,17]. It is
that MAP can interact with ICAM-1 and mediate the adhesion of
S. aureus to endothelial cells [18]. At the same time, MAP can
block the binding of the LFA-1 (lymphocyte-function-associated
antigen) on the surface of neutrophils and ICAM-1, and then pre-
vent leucocyte adhesion, diapedesis and extravasation [18–22].
MAP can also be capable of modulating the T-cell response, in-
duce T-cell death, and then affecting the severity of chronic dis-
ease, such as osteomyelitis and abscess formation [23]. In
addition, MAP induces the secretion of the proinﬂammatory
cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha
(TNF-a) by CD14+ leukocytes. It suggests that MAP plays a sig-
niﬁcant role in both septic shock and fever [24]. Previous study
shows that the expression of MAP is increased in the inactive
mutant of agr [17]. However, little data about how MAP is reg-
ulated by agr is presented.
In this study, we have investigated the expression of MAP in the
RNAIII defective mutant. In the further study, we have demon-
strated that RNAIII can up-regulate the expression of MAP by
base-pairing with its mRNA. The binding site at RNAIII has been
also investigated in this work.lsevier B.V. All rights reserved.
Fig. 2. The targets of RNAIII were captured by Streptavidin MagneSphere. The
biotinylated RNAIII was bound to Streptavidin MagneSphere, and then incubated
with total RNA of S. aureus. The captured RNAs were further analyzed by RT-PCR.
map mRNA was in the pool of RNAIII targets.
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2.1. map mRNA was upregulated by RNAIII
Previous studies showed that map is regulated by the agr sys-
tem [8,17]. So we veriﬁed if the map mRNA level was different
between RN6390 and RN6911 (agr mull) [25]. The total RNAs
of RNA6390 and RN6911 were extracted and the qRT-PCR was
used to detect the mRNA level in two strains. The Fig. 1A showed
that the mRNA level of map was decreased in the RNA6911 com-
pared to RNA6390. Then the 50UTR and coding sequence of the
ﬁrst seven amino acids of map mRNA was fused with lacZ and
the fusion was transformed into RN6390 and RN6911. In
RN6911, the b-galactosidase activity of Umap-lacZ was signiﬁ-
cantly decreased compared with RN6390 (Fig. 1B). The results
suggested that map was indeed activated by agr system. Mean-
while, the mechanism of this regulation is still not unclear. As
the key effecter of the agr system, RNAIII can inﬂuence the
expression of several proteins [9,11,15,25,26]. So we conducted
the RNAIII deletion mutant (DRNAIII) from S. aureus 8325-4 and
analyzed the change of expression level of map mRNA. We found
that the expression level of map is decreased signiﬁcantly in
DRNAIII (Fig. 1C). In the further study, the Umap-lacZ plasmid
was transformed into wild-type (WT), DRNAIII and RNAIIIR. It
was showed that the b-galactosidase activity of Umap-lacZ in
DRNAIII was signiﬁcantly decreased compared with that in wild
type (Fig. 1D). These results suggested that the map mRNA was
upregulated by RNAIII.Fig. 1. (A) qRT-PCR quantiﬁcation of the expression of map in RN6390 and RN6911 (agr
with RN6390. The values are an average of three replications (⁄⁄P < 0.01). (B) Determinati
b-galactosidase activity of Umap-lacZ in RN6911 was signiﬁcantly decreased compared
(⁄⁄P < 0.01). (C) qRT-PCR quantiﬁcation of the expression of map in WT (wild-type), DR
expression level of map was decreased signiﬁcantly in the DRNAIII. The values are an
activities of Umap-lacz fusion in WT (wild-type), DRNAIII (RNAIII deletion mutant), DRNA
Umap-lacZ in DRNAIII was signiﬁcantly decreased compared with wild type. The results2.2. RNAIII could bind map mRNA directly
RNAIII can inﬂuence the target RNAs by interacting with them
[10,11,15,27], so we detected that if RNAIII could binding to the
map mRNA directly. Firstly, we bound the biotinylated-RNAIII to
the magnetic beads, and then the total RNA of S. aureus was incu-
bated with RNAIII. After washing, the speciﬁc RNAs which bound
with RNAIII were detected by RT-PCR using speciﬁc primers listed
in the Table 2. It was showed thatmapmRNAs were in the enriched
pool of RNAIII targets (Fig. 2).
2.3. RNAIII could bind to the 50UTR of map mRNAs using its hairpin 4
(108–135 nt)
Previous studies have revealed that RNAIII acts as an antisense
RNA to up-regulate or down-regulate the target mRNAs [10,11,null). The mRNA level of map was decreased signiﬁcantly in the RN6911 compared
on of the b-galactosidase activities of Umap-lacz fusion in RN6390 and RN6911. The
with RN6390. The results represented a mean of three independent experiments
NAIII (RNAIII deletion mutant) and RNAIIIr (DRNAIII restoring RNAIII activity). The
average of three replications (⁄⁄P <0.01). (D) Determination of the b-galactosidase
III-RM and RNAIIIr (DRNAIII restoring RNAIII activity). The b-galactosidase activity of
represented a mean of three independent experiments (⁄P < 0.05).
Fig. 3. (A) The secondary structure model of RNAIII from Benito et al. [9]. (B) Sequence alignment between RNAIII and map mRNA. The sequence similarities between RNAIII
and map mRNA was analyzed. At the same time, some nucleotides in map mRNA were replaced to disrupt the formation of duplex between RNAIII and map mRNA. (The red
bold colored fragment was the start codon). Then the fragment containing 50UTR and coding sequence of the ﬁrst seven amino acids of MAP was fused with lacZ to generate
Umap-lacZ. The mutant fragment was fused with lacZ to generate mUmap-lacZ. The DRNAIII-RM strain contained the part sequence of RNAIII in which the hairpin 4 were
replaced by the complementary point mutations of 50UTR of map mRNA. (C) qRT-PCR quantiﬁcation of the expression of map in WT (wild-type), DRNAIII (RNAIII deletion
mutant), DRh4 (8325-4 with an 108–135 nt of RNAIII mutation), Rh4 (DRNAIII restoring hairpin 4 activity) and RNAIIIr (DRNAIII restoring RNAIII activity). The values are an
average of three replications (⁄⁄P < 0.01). (D) Determination of the b-galactosidase activities of mUmap-lacz fusion in WT (wild-type), DRNAIII and DRNAIII-RM. No difference
was detected between WT and DRNAIII. In DRNAIII-RM, the b-galactosidase activities of mUmap-lacz were increased compared with DRNAIII. The results represented a mean
of three independent experiments (⁄⁄P < 0.01).
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(Fig. 3A) [9]. Sequence analysis showed that the 108–135 nt of
RNAIII (hairpin 4) could bind the 50UTR of map mRNA (Fig. 3B).
So we constructed the hairpin 4 deletion mutant (DRh4). At the
same time, the hairpin 4 was transferred to DRNAIII, named as
Rh4r. The mRNA level of map was detected in the DRh4 and
Rh4r by qRT-PCR. It was found that the mRNA levels of map
was decreased in the DRh4 and no signiﬁcant difference was ob-
served between WT and Rh4r (Fig. 3C). These results suggested
that hairpin 4 of RNAIII was essential for the expression of
MAP. To verify whether MAP protein expression was directly
regulated by RNAIII, the mutant of MAP mRNA with point
substitutions disrupting the base-pairing sites (Fig. 3B) was fused
with lacZ and the fusion vector was transformed into wild-type
and DRNAIII. b-Galactosidase activities of mUmap-lacZ have no
difference between two groups (Fig. 3D). These observations sug-
gested that RNAIII could upregulate the expression of MAP
directly.
In the further study, the RNAIII with the mutated hairpin 4,
which carried the complementary sequence of 50UTR mutant of
map mRNA, was intergraded into the genome of DRNAIII to gener-
ate the strain of DRNAIII-RM (Fig. 3B). And then the mUmap-lacZ
and Umap-lacZ were transformed into the DRNAIII-RM. The activ-
ities of b-galactosidase of different strains were measured. It was
found that the b-galactosidase activities of mUmap-lacZ in
DRNAIII-RM were increased compared with the activities in the
DRNAIII (Fig. 3D). It was also found that the activities of Umap-lacZ
in DRNAIII-RM were similar to that in DRNAIII (Fig. 1D). This result
further conﬁrmed that RNAIII could base-pair with 50UTR of map
mRNA with its hairpin 4.3. Discussion
Secretory proteins are up-regulated by agr system whereas sur-
face proteins are down-regulated in S. aureus [25]. As the key
effecter of the agr system, RNAIII can up-regulate target genes,
hla, and down-regulate target genes, spa, coa and rot at the level
of transcription [10,11,15,27]. It directly control target genes
expression through different regions although sometimes a limited
number of base pairings is involved in the two loop–loop interac-
tions [15]. Until mow, most studies focus on the targets which are
down-regulated by RNAIII. Although RNAIII is the ﬁrst example of
an antisense RNA whose interaction with the target mRNA leads to
stimulation of translation rather than inhibition in S. aureus [10],
little targets which are upregulated by RNAIII are revealed. In this
report, we have shown that MAP, which is an important mediator
in the immune response to staphylococcal infection, is one of up-
regulated targets of RNAIII. We have observed the direct binding
between the RNAIII and map mRNA. The data presented here indi-
cate that RNAIII can bind to 50UTR of mapmRNA with its hairpin 4.
In summary, our data reveal a new target which was positively
regulated by RNAIII. It will improve the understanding about the
mechanism by which RNAIII directly regulates its targets
positively.
4. Materials and methods
4.1. Bacterial strains and growth conditions
The strains used in this study are listed in Table 1. Strains were
grown in 5 ml of brain heart infusion (BHI) or Luria–Bertani (LB)
Table 1
Bacterial strains and plasmids.
Strain or
plasmid
Comments Source or
reference
Strain
S. aureus
8325-4 Wild-type, rsbU [32]
RN6390 Derivative of 8325-4, agr positive [25]
RN6911 RN6390: Dagr region::tetM [25]
DRNAIII 8325-4 with an RNAIII::kan mutation This study
DRh4 8325-4 with an 108–135 nt of RNAIII mutation This study
Rh4 DRNAIII restoring hairpin4 activity This study
RNAIIIr DRNAIII restoring RNAIII activity This study
DRNAIII-RM DRNAIII restoring part RNAIII in which the
hairpin4 is replaced by the complementary
point mutations of 50 UTR of map mRNA
RN4220 Restriction-negative strain, 8325 derivative [33]
E. coli
DH5a A host strain for cloning Transgene
Plasmids
pMD19T E. coli cloning vector, ampR TaKaRa
pMD20T E. coli cloning vector, ampR TaKaRa
pAUL-A Temperature-sensitive S. aureus suicide vector;
Emr
[34]
pAUL-A-
DRNAIII
pAUL-A containing whole RNAIII gene This study
pOS1 E. coli–S. aureus shuttle vector [35]
pOS1-lacZ pOS1 (E. coli–S. aureus shuttle vector) contains a
copy of lacZ encoding b-galactosidase without
promoter and 50UTR; CmR
This study
pOS1-
Umap-
lacZ
50UTR and and coding sequence of the ﬁrst 6
amino acids of map-lacZ fusion(Umap::lacZ)
shuttle vector, a derivative of pOS1
This study
pOS1-
mUmap-
lacZ
Mutant 50UTR and coding sequence of the ﬁrst
6 amino acids of map-lacZ
fusion(mUmap::lacZ) shuttle vector, a
derivative of pOS1
This study
Table 2
Sequences of forward and reverse primers used in this study.
Primer/
sequence
Oligonucleotide sequence (50 to 30)
Up-RNAIIIF-
EcoRI
CATCCGGAATTCTATTACTAAAGGTAAAAGTA
Up-RNAIIIR-
KpnI
ATTACAGGTACCAGTTATATTAAAACATGCTA
DownRNAIIIF-
KpnI
ATAACTGGTACCTGTAATGAAGAAGGGATGAG
Down-RNAIIIR-
SalI
ACACGCGTCGACATGATTTACGTTTTCCAGAA
rs-RNAIIIF TCTAGATAGTCGACATTTACCTATATTTTTAGCT
rs-RNAIIIR GATATGCATGAATTC GCCCGAAATA ATATTTAACA
Rh4r-F CCAATCGGTGACTTAGTAAAATGGATTATCGACACG
Rh4r-R GATCCGTGTCGATAATCCATTTTACTAAGTCACCGATTG
GGTAC
pOS1-F ACG TAACGGCTTC ATCCAA
RNAIII RT-F CCTAGATCAC AGAGATGTGA TGG
RNAIII RT-R AATACATAGC ACTGAGTCCA AGG
RNAIII-Rh4-F GGAATCGGGGTACC AGATCACAGA GATGTGATGG
Rh4C CAAT CGGTGACTTA GTAAAATGGA TTATCG
Rh4-F A TTTCAA AGTGAACAAA TTCAC
Rh4-R TTCACTTTGA AATGATATCT
RNAIII-Rh4-R ATCATCGCGG ATCCCAAAAG GCCGCGAGCT T
RMF ATCTGGTAAT TGACGGATCA TTTGAAATGA TATCT
RMR AATT ACCAG A TAAATTATC AGTGAACAAA TTCAC
Umap-lacZF GATATGCATGAATTC CTAATAATAA ATTTGCTAAT
Umap-lacZR ATCATCGCGGATCCCCAATCAATGACTTAAATTTCAT
mUmap-lacZR ATCATCGCGGATCCCCATGATCCGTCAATTTGGTCATAAA
TTATCTCTCC
RNAIIIF AGATCACAGA GATGTGATGG
RNAIIIR CAAAAGGCCGC GAGCTTGGG
map UTRF GATTTTGTTTTTTTCACC
map UTRR ATTAAAGTTTGCACCTG
map RTF TTAGCCAACTGAATCTGC
map RTR GATGCCTCTTTCACTTTT
RNAIII RTF CCTAGATCAC AGAGATGTGA TGG
RNAIII RTR AATACATAGC ACTGAGTCCA AGG
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test tube. Cells from 1 ml of preculture were transferred to 100 ml
of BHI or LB medium in a 500-ml ﬂask and incubated at 37 C on a
rotary shaker at 200 rpm. S. aureus strains were routinely grown in
BHI and E. coli strains were grown in LB medium either with no
antibiotics, or with 20 lg ml1 erythromycin, 100 lg ml1 ampicil-
lin, 50 lg ml1 kanamycin, and 20 lg ml1 chloramphenicol,
respectively.
4.2. Construction of RNAIII deletion mutant (DRNAIII)
The mutant was constructed using the method described previ-
ously [28] with some modiﬁcations. In order to create a deletion
mutant of RNAIII in the chromosome of 8325-4, two regions of
DNA ﬂanking the RNAIII gene were ampliﬁed by PCR using the
primers (Up-RNAIIIF-EcoRI and Up-RNAIIIR-KpnI; Down-RNAIIIF-
KpnI and Down-RNAIIIR-SalI) with restriction sites listed in Table
2. The upstream fragment (502 bp) was digested with EcoRI and
KpnI, and the downstream fragment (591 bp) was digested with
KpnI and SalI. The two fragments were cloned together into
pMD19T digested with EcoRI and SalI. The resulting construct
was digested with KpnI, and then a 1.6-kb kanamycin cassette
which was ampliﬁed from the plasmid of pTZ-TRAP::kan provided
by Dr. Balaban N was inserted. The resulting plasmid was digested
with EcoRI and SalI, and a fragment harboring kanamycin resis-
tance between the upstream and downstream fragments was li-
gated into pAUL-A digested with EcoRI and SalI to create plasmid
pAUL-A-DRNAIII. pAUL-A has a temperature-sensitive origin of
replication that is active in S. aureus at 30 C but not at 42 C.
The recombinant plasmid initially isolated from Escherichia coli,
was introduced into S. aureus RN4220 by electroporation and col-onies resistant to kanamycin and erythromycin were selected after
growth at 30 C. The resistant clones were subjected to a tempera-
ture shift to 42 C to select the plasmid integration into the
chromosome. Bacteria resistant to kanamycin but sensitive to
erythromycin were selected. The mutation was conﬁrmed by
PCR, and followed by transduction into strains 8325-4 with phage
U11 to create the mutant strains from which the coding region of
RNAIII was deleted (Table 1).
4.3. Restoring RNAIII activity
Primers rs-RNAIIIF and rs-RNAIIIR (listed in Table 2) were de-
signed to PCR-amplify a 1096 bp fragment encompassing the gene
encoding for RNAIII, the promoter region and termination site with
SalI/EcoRI sites. S. aureus 8325-4 chromosomal DNA was used as
the template. The PCR product (‘‘whole RNAIII’’) was digested
and cloned into the SalI/EcoRI digested pMAD, which could repli-
cate in E. coli at 37 C and in S. aureus at 30 C and could be used
as a suicide vector when grown at 42 C in S. aureus. The resulting
plasmid (pMAD-rs-RNAIII) was transformed into E. coli DH5a. Cells
were selected on LB plates containing 100 lg ml1 ampicillin. Plas-
mid was isolated from positive clones and used to transform S. aur-
eus RN4220 cells. The transformants were selected on tryptic soy
agar plates containing 10 lg ml1 erythromycin at 30 C. Then
the plasmid was isolated from the positive clone (RN4220 contain-
ing pMAD-rs-RNAIII) and transformed to DRNAIII-8325. The trans-
formants were selected on tryptic soy agar plates containing
10 lg ml1 erythromycin at 30 C for 48 h, and then transferred
to 42 C for 12 h. The restoring colonies (RNAIIIr) were conﬁrmed
by PCR (primers: rs-RNAIIIF/rs-RNAIIIR) and RT-PCR (primers:
RNAIII RT-F/RNAIII RT-R) (Table 2).
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Primers Rh4r-F and Rh4r-R (listed in Table 2) were annealed to
double-strands fragment encompassing the gene encoding hairpin
4 of RNAIII with KpnI and BamHI sites. The product was digested
and cloned into RNAIII-promoter-pOS1 (RppOS1), which included
the promoter of RNAIII. The resulting plasmid (RppOS1-Rh4) was
transformed into E. coli DH5a by electroporation. Positive clones
were selected on LB plates containing 100 lg ml1 ampicillin.
The recombinant plasmid was isolated from positive clones and
transformed to S. aureus RN4220 cells, and transformants were
selected on tryptic soy agar plates containing 10 lg ml1 chloro-
mycetin at 37 C. The positive clone (RN4220 containing RppOS1-
Rh4) was selected by colony PCR. Then the plasmid was isolated
and transformed to DRNAIII. The transformants were selected on
tryptic soy agar plates containing 10 lg ml1 chloromycetin at
37 C for 20 h. The plasmid of positive restoring colonies (Rh4r)
was extracted and conﬁrmed by PCR using primers pOS1-F and
Rh4r-R (Table 2).
4.5. Construction of hairpin4-RNAIII deletion mutant (DRh4)
Primers RNAIII-Rh4-F/Rh4-R and Rh4-F/RNAIII-Rh4-R (Table 2)
were designed to PCR-amplify two fragments. The overlapping
PCR was used to amplify the RNAIII gene fragment in which hairpin
4 was deleted, using these two fragments as the template with
primers RNAIII-Rh4-F/RNAIII-Rh4-R. The PCR product was digested
and cloned into the RNAIII-promoter-pOS1 (RppOS1), which could
replicate in E. coli and in S. aureus at 37 C. The resulting plasmid
(RppOS1-DRh4) was transformed into E. coli DH5a. The positive
clones were selected on LB plates containing 100 lg ml1 ampicil-
lin. The recombinant plasmid was isolated from positive clones and
transformed into S. aureus RN4220 cells, and transformants were
selected on tryptic soy agar plates containing 10 lg ml1 chloro-
mycetin at 37 C. The positive clone (RN4220 containing RppOS1-
DRh4) was selected by colony PCR using primers RNAIII-Rh4-F/
RNAIII-Rh4-R and Rh4C/ RNAIII-Rh4-R. Then the plasmid was iso-
lated and transformed into DRNAIII. The transformants were se-
lected on tryptic soy agar plates containing 10 lg ml1
chloromycetin at 37 C for 20 h. The positive clone (DRh4) contain-
ing the plasmid RppOS1-DRh4 was conﬁrmed by PCR using prim-
ers RNAIII-Rh4-F/RNAIII-Rh4-R and Rh4C/RNAIII-Rh4-R.
4.6. Construction of the DRNAIII-RM
Primers rs-RNAIIIF/ RMF and RMR/rs-RNAIIIR (Table 2) were de-
signed to PCR-amplify two fragments. The overlapping PCR was
used to amplify the RNAIII gene fragment in which hairpin4 was
replaced by the complementary point mutations of MAP mRNA
UTR (Fig. 3B), using these two fragments as the template with
primers rs-RNAIIIF/rs-RNAIIIR. The PCR product was digested and
cloned into the SalI/EcoRI digested pMAD, which could replicate
in E. coli at 37 C and in S. aureus at 30 C and could be used as a
suicide vector when grown at 42 C in S. aureus. The resulting plas-
mid (pMAD-DRNAIII-RM) was transformed into E. coli DH5a. Cells
were selected on LB plates containing 100 lg ml1 ampicillin. Plas-
mid was isolated from positive clones and used to transform S. aur-
eus RN4220 cells. The transformants were selected on tryptic soy
agar plates containing 10 lg ml1 erythromycin at 30 C. Then
the plasmid was isolated from the positive clone (RN4220
containing pMAD-DRNAIII-RM) and transformed to DRNAIII. The
transformants were selected on tryptic soy agar plates containing
10 lg ml1 erythromycin at 30 C for 48 h, and then transferred
to 42 C for 12 h. The colonies (DRNAIII-RM) were conﬁrmed by
PCR and RT-PCR (primers: rs-RNAIIIF/RMF and RMR/rs-RNAIIIR)
(Table 2).4.7. Quantitative reverse transcription PCR (qRT-PCR)
Total bacterial RNA was extracted from S. aureus which were
grown for 6 h with shaking at 37 C using Trizol (invitrogen) as
previously described [29]. DNase digestion of 80 ll of total RNA
was performed with 10 U of RNase-free DNase I (Promega) and
10 ll of the 10 reaction buffers in a total reaction volume of
100 ll for 30 min at 37 C. For cDNA synthesis, 1 lg of total RNA
was mixed with 500 ng of random hexamer (Promega). Samples
were incubated at 65 C for 10 min with 5 ll of 5 ﬁrst-strand buf-
fer, 2 ll of 5 mM dNTP, 20 U of RNasin (Takara), 1 ll of M-MLV re-
verse transcriptase (Promega) and distilled water to a total volume
of 25 ll. The qRT-PCR reaction mixture contained 12.5 ll of 2
SYBR green PCR mix (GenePharma), 0.3 lM of gene-speciﬁc for-
ward and reverse primers, and 1 ll of template, made up to a ﬁnal
volume of 25 ll with distilled water. The primers are shown in
Table 2. Cycling parameters were set as follows: initial activation
step at 95 C for 10 min, denaturation at 94 C for 30 s, annealing
at 58 C for 30 s, and extension at 72 C for 40 s. Melting curve
analysis was performed at from 58 C to 95 C with stepwise ﬂuo-
rescence acquisition at every 1 C s1. Melting curves observed for
each gene were conﬁrmed to correspond to the correct amplicon
size by agarose gel electrophoresis of the PCR products. The levels
of gene expression were calculated by relative quantiﬁcation using
16s rRNA as the endogenous reference gene. All samples were
ampliﬁed in triplicate and the data analysis was carried out using
the MxPro qRT-PCR system software (Stratagene).
4.8. Construction of lacZ reporter vector
The Umap fragment was ampliﬁed by PCR from S. aureus 8325-4
chromosomal DNA with primers Umap-lacZF and Umap-lacZR and
The Umap fragment was ampliﬁed with primers Umap-lacZF and
mUmap-lacZR (Table 2). The PCR products were digested with
EcoRI and BamHI, and ligated into EcoRI and BamHI-digested
pOS1-lacZ plasmid DNA resulting in the in-frame fusion of lacZ
to the ampliﬁed fragments. The recombinant plasmids were trans-
formed into DH5a, then electrotransfected to S. aureus RN4220.
The plasmid was isolated from RN4220, then electrotransfected S.
aureus 8325-4 and DRNAIII.
4.9. b-Galactosidase assay
S. aureus cells containing lacZ fusions were grown in BHI broth
as described above, and 1 ml culture was centrifuged. The cells
were prepared for the assay as described before with some modi-
ﬁcation [17]. Brieﬂy, the pellet was washed in PBS, and then the
cells were adjusted to an OD600nm of 1 in a volume of 500 ll. The
cells were sedimented by centrifugation and the pellet was
resuspended in 500 ll lysis buffer (0.01 M potassium phosphate
buffer, pH 7.8, 0.015 M EDTA, 1% Triton X-100) containing lyso-
staphin at the ﬁnal concentration of 20 lg ml1, and incubated at
37 C for 30 min, with gentle shaking. The culture was centrifuged
at 20 000g for 30 min. The supernatant was subjected to galactosi-
dase assays according to the method described by Miller [30].
4.10. In vitro transcription
The RNAIII gene or map 50UTR was ampliﬁed from the genome
of S. aureus 8325-4 with the primers (RNAIIIF, RNAIIIR; map UTRF,
map UTRR) in Table 2. And then the product was cloned into the
pMD20T vector (TaKaRa), generating RNAIII-pMD20T. Plasmid
RNAIII-pMD20T was digested to completion with BamHI (TaKaRa)
prior to in vitro transcription. RNA was transcribed in vitro using
SP6 RNA polymerase (TaKaRa) as follows. Transcription mixtures
(20 ll) contained 1 ll SP6 RNA polymerase (TaKaRa), 2 ll 10
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plasmid, 1 ll 100 lM each of ATP, CTP, GTP, UTP and 20 units of
RNase inhibitor (TaKaRa). Transcription was carried out at 37 C
for 60 min. Thereafter, the reactions were treated with one unit
of DNaseI (Promega) at 37 C for 15 min. The enzyme was heat
inactivated for 10 min in the presence of 5 mM EDTA. RNA was
puriﬁed by denaturing gel electrophoresis by RNA elution buffer
(0.1 M sodium acetate, 0.1% SDS, 10 mM EDTA) at 4 C overnight.
RNA eluted from the gel was precipitated with three volumes of
100% ethanol, dried, resuspended in TE (10 mM Tris (pH 7.5),
1 mM EDTA) and stored at 20 C.
4.11. Capture of RNAIII targets
The RNAIII (100 pmol) was dephosphorylated by 1 U of alkaline
calf intestine phosphatase (TaKaRa) for 30 min at 37 C. The reac-
tion was terminated by phenol/chloroform (1:1) extraction. The
RNA samples were then further extracted with chloroform and
recovered by ethanol precipitation. The RNA linker (TaKaRa) with
biotin was then ligated to the 30 end of the RNA fraction, using a
method described previously [31] with some modiﬁcations. The
recovered RNA (50 pmol) was mixed with 100 pmol of RNA linker,
heat-denatured at 95 C for 5 min, and then quick-chilled on ice.
The ligation reaction was performed at 17 C for 12 h with 50 U
of T4 RNA ligase (New England Biolabs). After the reaction, the
RNA was recovered. The biotinylated RNA (20 pmol) was incubated
with 20 ll of Streptavidin MagneSphere Paramagnetic Particles
(SA-PMPs, Promega) for 10 min at room temperature. The total
RNA (5 lg) in TMN buffer was added to the SA-PMPs and incubated
for 10 min at 37 C. The SA-PMPs were washed three times with
0.5 SSC (300 ll per wash). After each wash, the SA-PMPs were
captured using a magnetic stand and the wash solution was re-
moved. Then, the SA-PMPs were resuspended in RNase-free water
and used as the template for RT-PCR.
4.12. Statistical analysis
All quantitative data were analyzed using Student’s t-tests.
P < 0.05 was considered to be statistically signiﬁcant.
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